Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
49.74B
Market cap49.74B
Price-Earnings ratio
51.20
Price-Earnings ratio51.20
Dividend yield
—
Dividend yield—
Average volume
3.79M
Average volume3.79M
High today
$87.11
High today$87.11
Low today
$84.93
Low today$84.93
Open price
$85.65
Open price$85.65
Volume
3.56M
Volume3.56M
52 Week high
$96.29
52 Week high$96.29
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

As of today, Edwards Lifesciences(EW) shares are valued at $86.29. The company's market cap stands at 49.74B, with a P/E ratio of 51.20.

On 2026-09-26, Edwards Lifesciences(EW) stock traded between a low of $84.93 and a high of $87.11. Shares are currently priced at $86.29, which is +1.6% above the low and -0.9% below the high.

The Edwards Lifesciences(EW)'s current trading volume is 3.56M, compared to an average daily volume of 3.79M.

During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $96.29 at its peak.

During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $96.29 at its peak.

EW News

Simply Wall St 13h
Why Edwards Lifesciences Is Getting Attention Today

Edwards Lifesciences (EW) is drawing investor attention after hiring Ganesh Mayya from GE HealthCare to lead a new digital product engineering group focused on...

Why Edwards Lifesciences Is Getting Attention Today
TipRanks 21h
Edwards Lifesciences Updates Key Feasibility Study for SAPIEN M3 Mitral Valve

Edwards Lifesciences Corp. (EW) announced an update on their ongoing clinical study. The Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatm...

Analyst ratings

73%

of 30 ratings
Buy
73.3%
Hold
26.7%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.